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Abstract:  
Introduction: Delirium, a serious condition observed in critically ill patients, clinically 
presents with impaired cognition and consciousness. The relationship between 
delirium and peripheral levels of insulin growth factor-1 (IGF-1) is unclear. Thus we 
conducted a meta-analysis to address this issue. 
Methods: Seven major electronic databases were searched from inception until 
October 2, 2017 to obtain relevant clinical variables to compare the difference in 
IGF-1 levels between delirious and non-delirious elderly in-patients. A random effects 
meta-analysis was conducted. 
Results: We studies 10 articles involving 294 delirious patients (mean age 73.0 years) 
and 604 non-delirious patients (mean age 76.9 years). We found that peripheral levels 
of IGF-1 in patients with delirium were significantly lower than in those without 
delirium (Hedges` g = -0.209, 95% confidence interval [CI] = -0.393 to -0.026, p = 
0.025). Meta-regression analyses found that no variables such as percentage of 
cognitive impairment, mean age, and female proportion contribute to heterogeneity in 
terms of the entire population. 
Conclusions: Our data suggests that lower peripheral levels of IGF-1 could be 
associated with a higher incidence of delirium among elderly patients. Further 
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prospective studies with larger sample sizes are needed to investigate the association 
between peripheral levels of IGF-1 and delirium. 
Keywords: Biomarker, Delirium, Elderly, IGF-1, Meta-analysis 
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1. Introduction 
Delirium, which clinically presents with impairment in cognition, consciousness, 
psychomotor behavior, and attention (Ely et al., 2001), may manifest with a wide 
range of subtypes ranging between hyperactive and hypoactive conditions (Steiner, 
2011). Clinically, it usually presents with a sudden onset, which then fluctuates 
between hours and days and is generally a reversible condition (Yudofsky & Hales, 
2008). Etiologically, delirium indicates an organic decline in cerebral function 
resulting from variable mechanisms. For example, the etiology of alcohol-withdrawal 
delirium differs from that causing postoperative delirium (Steiner, 2011). Incidence of 
delirium varies depending on the purpose of investigation. Incidence of delirium 
varies between 9% and 43% among geriatric patients hospitalized for variable 
medical conditions (Laurila, Pitkala, Strandberg, & Tilvis, 2002; O'Keeffe & Gosney, 
1997). Delirium is commonly observed in elderly patients post surgery, and the 
incidence of postoperative delirium (POD) ranges widely between 10% and 65% 
(Radtke et al., 2010; Rudolph & Marcantonio, 2011). Delirium is a serious 
neuropsychiatric condition with a substantial impact owing to increased morbidity and 
mortality, high healthcare costs and prolonged hospitalization associated with it 
(Hustey, Meldon, Smith, & Lex, 2003; Meagher et al., 2007). Regarding mortality 
rates, reportedly, delirious patients show an overall hazard ratio of 1.9 in elderly 
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patients in a meta-analysis study (Witlox et al., 2010). Given the inadequate 
understanding of its multifactorial aetiopathogenesis (Hughes, Patel, & Pandharipande, 
2012), researchers are interested in studying the etiology of delirium to better predict 
its course and prognosis in clinical settings. Although previous reviews (Khan, 
Zawahiri, Campbell, & Boustani, 2011) have demonstrated the limited role of 
biomarkers in detection of delirium, researchers have been trying to identify specific 
biomarkers linked to this condition such as insulin growth factor-1 (IGF-1).  
IGF-1 is a member of the IGF family with 70 amino acid peptides, and is primarily 
produced in the central nervous system (CNS) and peripheral tissues such as the liver 
(Le Roith, 2003; Torres-Aleman, 2010). IGF-1 in the CNS plays a vital role in 
enhancing neuronal survival, differentiation, synaptogenesis, and recovery from 
neural injury (D'Ercole, Ye, & O'Kusky, 2002). IGF-I blocks apoptosis in damaged 
neurons via several mechanisms, such as delay of apoptosis via activation of 
PI3K/Akt kinase and Ras/Raf/MEK/ERK pathways and results in long-term survival 
(Gluckman et al., 1998; Parrizas & LeRoith, 1997; Peruzzi et al., 1999). Clinically, 
studies have explored its neuroprotective role and association with neurocognitive 
disorders such as Alzheimer’s disease (AD), of which is involved with delirium 
(Kooijman, Sarre, Michotte, & De Keyser, 2009; Lackey, Gray, & Henricks, 2000). 
Additionally, IGF-1 deficiency in humans may cause growth abnormalities, including 
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a smaller sized brain and mental retardation (Werner & LeRoith, 2014). Furthermore, 
it has been reported that serum IGF-1 levels positively correlate with cognitive 
performance in healthy elderly subjects (Al-Delaimy, von Muhlen, & Barrett-Connor, 
2009; Aleman et al., 2000). 
Moreover, as researchers keenly investigating the association between peripheral 
levels of IGF-1 and delirium, several studies have explored the significance of this 
correlation in patients undergoing surgery or those with acute medical illnesses 
(Adamis et al., 2009; Adamis et al., 2007; Cerejeira, Batista, Nogueira, Vaz-Serra, & 
Mukaetova-Ladinska, 2013; Egberts et al., 2015; Lemstra, Kalisvaart, Vreeswijk, van 
Gool, & Eikelenboom, 2008; Morandi et al., 2011; Wilson, Broadhurst, Diver, 
Jackson, & Mottram, 2005). While some studies report that lower peripheral levels of 
IGF-I could significantly increase the incidence of delirium (Cerejeira et al., 2013; 
Egberts et al., 2015; Morandi et al., 2011; Wilson et al., 2005), the opposite findings 
have also been reported by some others (Adamis et al., 2009; Adamis et al., 2007; 
Lemstra et al., 2008). Possible factors accounting for this discrepancy are 
inconsistency between recruited patients, such as postoperative or medically ill cases 
in terms of study designs or clinical status. Thus, the association between peripheral 
levels of IGF-I and incidence of delirium in a clinical setting needs to be further 
studied. Given these aforementioned gaps existing in literature, we performed a 
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comprehensive systematic review and meta-analysis investigating the association 
between peripheral levels of IGF-1 and delirium, specifically focusing on clinical 
status of patients. In addition to exploring the difference in this association between 
surgical or medically ill patients, we also attempted to determine possible factors 
affecting the correlation between delirium and IGF-1 levels. 
 
2. Materials and methods 
Our systematic review and meta-analysis was based on Meta-analysis Of 
Observational Studies in Epidemiology (MOOSE) guidelines (Stroup et al., 2000) 
(supplemental table S1) and was approved by the Institutional Review Board of the 
Tri-Service General Hospital (TSGHIRB: B-105-12). Two investigators (DJ Li and 
CS Chu) independently performed database searches, study selection, data extraction, 
and rating of the methodological quality of included studies. Disagreements between 
investigators were resolved thorough consensus. 
2.1. Database searches 
PubMed, Embase, ScienceDirect, ClinicalKey, Cochrane Library, 
ClinicalTrials.gov and ProQuest were systematically searched from the time of their 
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inception until October 2nd, 2017. Keywords used for our search included “(IGF OR 
IGF1 protein OR inflammation mediators OR insulin-like growth factor OR cytokine) 
AND (delirium OR acute confusion OR consciousness disturbance)” without any 
limitation about language. Detailed search strings used for the electronic database 
search and results are shown in the supplemental figure S1.  
2.2. Eligibility Criteria and Study Selection 
Eligibility criteria applied were: (1) case-control studies comparing peripheral 
IGF-1 levels between delirious patients and non-delirious controls, or cohorts with 
detailed baseline data and subsequent delirium risk; (2) those with a diagnosis of 
delirium based on the definite diagnostic systems or scales, such as confusion 
assessment method (CAM) (Inouye et al., 1990), the diagnostic and statistical manual 
of mental disorders, 3rd revision (American Psychiatric Association. 1980) and 
text-revision (DSM-IV-TR) (American Psychiatric Association. 2000), or Delirium 
observation screening scale (Schuurmans, Shortridge-Baggett, & Duursma, 2003), 
Richmond agitation-sedation scale (Sessler et al., 2002); (3) those in whom detailed 
methods for detecting peripheral IGF-1 were available; and (4) formal registered trials 
or formal published peer-reviewed articles. 
Exclusion criteria were: (1) studies without adequate non-delirious controls; (2) 
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articles without relation to the comparisons of peripheral IGF-1 levels in delirious 
patients and controls; (3) those irrelevant to delirium; (4) review articles/commentary 
articles/case reports/letter to editor; or (5) non-clinical trials in human. 
2.3. Methodological Quality Assessment 
The modified Newcastle-Ottawa Scale (NOS) was used to rate methodological 
quality of included studies (Wells GA). This scale considers three domains: selection 
of participants (maximum of four stars), comparability of groups (maximum of two 
stars), and measurement (maximum of three stars). Scores ranged from 0 (the lowest) 
to 9 (the highest), and a score equal to 7 indicated high methodological quality. 
2.4. Data Extraction 
A predetermined data extraction list was used to extract data for this meta-analysis. 
To be specific, the extracted data included basic characteristics of participants (mean 
age and percentage of female), mini-mental status examination (MMSE), and duration 
of hospitalization.  
2.5. Meta-analysis  
The primary outcomes were the difference in peripheral IGF-1 levels in delirious 
patients compared to control groups who did not develop delirium in each recruited 
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study (calculated as Hedges’ g statistic). We did not choose difference in means as 
effect sizes (ESs) of our primary outcome due to presumed different units used among 
each study. For studies in which peripheral levels of IGF-1 were not available, 
outcomes were chosen as odd ratios (ORs) (Morandi et al., 2011; Wilson et al., 2005), 
or only a p value (Adamis et al., 2007) according to manuals of Comprehensive 
Meta-Analysis version 3.0. When peripheral levels of IGF-1 were not available in the 
included studies, we tried to contact the authors of such studies on at least two 
separate occasions to try and obtain additional raw data. Additionally, we converted 
ORs into ES using the formula suggested by the Cochrane Handbook (Higgins & 
Green, 2011) and derived ES using other statistical parameters such as the t or p value 
with the sample size when raw data were not available via email inquiry. We defined 
an ES and Hedges’ g less than 0 as “lower peripheral IGF-1 levels in patients with 
delirium than in controls without delirium”. Statistical significance was set as a 
two-tailed p value < 0.05. All meta-analytical procedures were performed using the 
Comprehensive Meta-Analysis version 3 (CMA ver. 3.0) (Biostat, Englewood, NJ) 
software. Meta-analyses were performed using random-effects models due to the 
anticipated heterogeneity across studies. Briefly, random-effects modeling is more 
stringent and therefore more convincing than fixed-effects modeling and incorporates 
a between-study variance in the calculations (Borenstein, Hedges, Higgins, & 
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Rothstein, 2010).  
2.6. Heterogeneity, publication bias, sensitivity test, and meta-regression 
We used the Cochran’s Q test and the corresponding p value to investigate potential 
heterogeneity among recruited studies (Higgins & Thompson, 2002). The I2 metric 
was used to investigate the proportion of variance between recruited studies 
(Borenstein, Higgins, Hedges, & Rothstein, 2017). The publication bias was 
determined by visual examination of funnel plots in situations of less than 10 studies 
(Higgins & Green, 2011) and using thorough Egger’s regression analysis if there were 
more than 10 studies (Egger, Davey Smith, Schneider, & Minder, 1997). In situation 
of significant publication bias, we arranged Duval and Tweedie`s trim and fill test to 
adjust the results of meta-analysis (Duval & Tweedie, 2000). Additionally, we 
performed sensitivity testing with one study removal test to investigate potential 
confounding by any one of the outlier in the recruited studies, which had been widely 
used in meta-analysis (Tobias, 1999). Additionally, we performed meta-regression 
analysis using an unrestricted maximum likelihood method to explore potential 
moderators. Variables considered for meta-regression analyses were: mean age, 
female gender (%), MMSE score, and a total modified NOS scores. The 
meta-regression procedure was only performed when moderator variables were 
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available from more than 5 individual datasets. 
 
3. Results 
3.1. Studies included in the meta-analysis 
The whole search picture was depicted as figure 1 and supplemental figure S1. In 
brief, eighty-two articles enter the full-texts investigation stage, and seventy-two were 
excluded for specific reasons (see supplemental table S2). Finally, ten articles met our 
inclusion criteria (Adamis et al., 2007; Cerejeira et al., 2013; Chu et al., 2016; Cinar 
et al., 2014; Egberts et al., 2015; Lemstra et al., 2008; Morandi et al., 2011; Shen, 
Shao, Chen, & Guo, 2016; Wilson et al., 2005; Yen et al., 2016). Peripheral levels of 
IGF-1 were obtained before delirium occurring in the seven studies (Cerejeira et al., 
2013; Chu et al., 2016; Cinar et al., 2014; Lemstra et al., 2008; Shen et al., 2016; 
Wilson et al., 2005; Yen et al., 2016). The participants in other three studies might be 
drawn IGF-1during delirious status (Adamis et al., 2007; Egberts et al., 2015; 
Morandi et al., 2011). 
3.2. Methodological quality assessment 
The mean modified NOS score was 7.4 with standard deviation (SD) = 0.5 across 
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the ten studies. The score in each domain of the modified NOS is shown in 
supplemental table S3. 
3.3. The main results of the meta-analysis comparing the levels of IGF-1 in patients 
with delirium and those without delirium 
Our systematic review and meta-analysis included 10 articles that met our inclusion 
criteria. Peripheral (serum or plasma) IGF-1 levels were measured in these ten studies. 
The quantitative determination of IGF-1 were taken from plasma (Cerejeira et al., 
2013; Wilson et al., 2005) and serum (Adamis et al., 2007; Chu et al., 2016; Cinar et 
al., 2014; Egberts et al., 2015; Morandi et al., 2011; Shen et al., 2016; Yen et al., 
2016), respectively. One study (Lemstra et al., 2008) mentioned that IGF-1 was 
assessed from blood sample (table 1). We found 294 delirious patients (mean age 73.0 
years, women 51.0 %) and 604 non-delirious patients (mean age 76.9 years, women 
53.2 %) among the 10 studies. Peripheral levels of IGF-1 in patients with delirium 
were significantly lower than in those without delirium (Hedges’ g = -0.209, 95% 
confidence interval (CI) = -0.393 to -0.026, p = 0.025] (Figure 2) with significant 
heterogeneity (Q value = 20.215, degree of freedom (df) = 9, I2 = 55.479%, p = 0.017) 
but no significant publication bias based on Egger’s test [t value = 1.060, df = 8, p = 
0.320]. 
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3.3.1. Sensitivity test 
The significant result of current meta-analysis became non-significant after 
removal of the datasets by Adamis, D. (2007) (Hedges’ g = -0.184, 95% CI = -0.374 
to 0.006, p = 0.058) (Adamis et al., 2007), Egberts, A. (2015) (Hedges’ g = -0.175, 
95% CI = -0.362 to 0.011, p = 0.066) (Egberts et al., 2015), Shen, H. (2016) (Hedges’ 
g = -0.125, 95% CI = -0.262 to 0.012, p = 0.073) (Shen et al., 2016), or Yen, T.E. 
(2016) (Hedges’ g = -0.193, 95% CI = -0.390 to 0.004, p = 0.055) (Yen et al., 2016). 
3.3.2 Meta-regression 
There was no any significant association between the differences of peripheral 
IGF-1 and clinical variables, including percentage of cognitive impairment (p=0.960), 
mean age (p=0.978), female proportion (p=0.721), mean MMSE scores (p=0.929), or 
quality of methodology as total modified NOS scores (p=0.270). 
 
4. Discussion 
To the best of our knowledge, the study is the first meta-analysis to address the 
association between peripheral IGF-1 and delirium and suggests that lower peripheral 
IGF-1 levels were found in patients with delirium compared with those without 
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delirium. Although causality of delirium and peripheral levels of IGF-1 has yet to be 
clarified, our study offers additional evidence supporting the immune-inflammatory 
hypothesis in delirium.  
The link between delirium and peripheral levels of IGF-1 can be mediated by 
cytokines released during inflammatory processes. Reportedly, a strong correlation is 
seen to exist between delirium and inflammation (Broadhurst & Wilson, 2001). 
Peripheral IGF-1 can cross the blood-brain barrier and play a role in neuronal function 
(Reinhardt & Bondy, 1994). It has been reported that administration of IGF-1 reduces 
secondary neuronal loss after transient neural injuries (Gluckman et al., 1998; Trejo, 
Carro, Garcia-Galloway, & Torres-Aleman, 2004). Similarly, replacement therapy 
with IGF-1 ameliorates diabetic neuropathy (Schmidt et al., 1999). Our study provides 
additional evidence to support this hypothesis. Lower peripheral levels of IGF-1 may 
possess lesser neuroprotective properties that is anti-apoptotic and anti-inflammatory 
actions, and contributed higher risk of delirium.  
Another factor involved in the connection between peripheral levels of IGF-1 and 
delirium may be relatively high mean age (almost above 70 years old) of participants 
in the included studies. Ageing, resulting from increased natural immunity activity, is 
a low level inflammatory status (Godbout & Johnson, 2009; Licastro et al., 2005). 
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Inflammation is related to several morbid conditions in the elderly such as 
cardiovascular disease (Pai et al., 2004) or Alzheimer’s disease (Casserly & Topol, 
2004). Furthermore, inflammation may result in the breakdown of the blood-brain 
barrier (Jeppsson et al., 1981) and decrease cholinergic transfer(Hammond, Meador, 
Aung-Din, & Wilder, 1987). Taken together, elevated levels of proinflammatory 
cytokine levels have been suggested to predispose the development of delirium in 
elderly, which is interpreted by the concept of immunosenescence (Godbout & 
Johnson, 2006). IGF-1, involving neuro-inflammation in the CNS (Trejo et al., 2004), 
may be also affected by ageing, be associated with delirium. However, our 
meta-regression showed that mean age did not significantly involve the relation 
between delirium and IGF-1. In addition to limited case numbers, relatively 
narrowing distribution of mean age may also restrict the statistical significance. 
Previous study also indicated that older patients undergoing cardiovascular surgery 
may develop delirium easily (Cinar et al., 2014). However, clearly more research is 
required to better understand this issue. 
It has been reported that IGF-1 levels positively correlate with cognitive 
performance in healthy elderly subjects (Al-Delaimy et al., 2009; Aleman et al., 2000). 
A meta-analysis has reported a significantly positive correlation between IGF-I and 
cognition in a healthy elderly population (Arwert, Deijen, & Drent, 2005). Another 
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study concluded that the IGFI levels showed an inverse correlation with cognitive 
dysfunction (Murialdo et al., 2001). In the present meta-analysis study, only two 
studies enrolled participants with baseline cognitive healthy, which was defined as an 
MMSE score of ≧ 24 or excluded when enrollment, and reported that lower 
peripheral levels of IGF-1 associated with incident of delirium in one study (adjusted 
Odd ratios [aORs] = 2.52, 95% CI = 1.19 to 5.43, p = 0.019)(Shen et al., 2016) but 
not another (aORs = 0.99, 95% CI = 0.96 to 1.01, p = 0.183) (Yen et al., 2016). For 
participants with baseline cognitive impairment, six (Adamis et al., 2007; Cerejeira et 
al., 2013; Chu et al., 2016; Cinar et al., 2014; Lemstra et al., 2008; Morandi et al., 
2011) out of eight (Adamis et al., 2007; Cerejeira et al., 2013; Chu et al., 2016; Cinar 
et al., 2014; Egberts et al., 2015; Lemstra et al., 2008; Morandi et al., 2011; Wilson et 
al., 2005) studies showed no significant differences between peripheral levels of 
IGF-1 and delirium. Therefore, cognitive impairment could be a possible confounder 
unfavorably affecting the association between delirium and peripheral levels of IGF-1. 
However, our meta-regression showed that baseline MMSE scores were not 
significantly linked to a correlation between delirium and IGF-1. This difference may 
be due to variable statistical methodology between dichotomous grouping [normal 
cognition vs. mild cognitive impairment (MCI) or dementia] and continuous variables 
of baseline MMSE scores. The fact that a limited number of cases were studied might 
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contribute to the insignificance observed with respect to baseline MMSE scores. 
Furthermore, some studies report that IGF-I levels were unaltered or increased among 
dementia patients (Nasman et al., 1995; Sara et al., 1982; Tham et al., 1993). A greater 
number of studies will need to be performed in future to investigate the correlation 
between cognition and IGF-1 to explore this inconsistency. 
Limitations of our study that need to be addressed are: 1) Studying a limited 
number of cases might be a confounding factor impacting the significance of 
outcomes. 2) Higher mean age would restrict the application of our findings to 
younger adults or adolescents. 3) We could not perform subgroup analyses comparing 
IGF-1 levels in different delirious classifications or diagnostic criteria (hypoactive vs 
hyperactive delirium and only CAM vs CAM plus DSM-III or -IV diagnosis) due to 
not enough studies. Future research is required to understand if this influences the 
relationship observed. 4) Peripheral levels of IGF-1 do not actually reflect the brain 
levels, and thus the pathogenesis between CNS levels of IGF-1and incident delirium 
need to be addressed in future studies. 
 
5. Conclusion 
In conclusion, lower peripheral levels of IGF-1 appear to be associated with 
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delirium among elderly patients. Further studies involving a greater number of 
participants and wider ranges of age would help to investigate the etiology and 
association between these two entities in future. Studies including more baseline 
variables and more specific description of diagnosing method to delirium could help 
us investigate more covariates and conduct subgroup analysis. 
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Figure legends: 
Figure 1. Flow chart showing the selection strategy and inclusion/exclusion criteria 
employed in our current meta-analysis. 
Figure 2. Forest plot of results of pooled effect sizes (Hedges’ g) and 95% confidence 
intervals (CIs) from pooled results of peripheral levels of insulin growth 
factor-1 (IGF-1) between delirious and non-delirious patients within the 
entire population. 
Abbreviation: CI: confidence interval; IGF-1: insulin-like growth factor-1 
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Table 1 
Summarization of recruited studies in current meta-analysis 
Author 
(year) 
Criteria Population or setting 
Delirium 
Non-delirium 
Mean age 
Female 
(%) 
Source IGF (ng/mL) Country 
Yen, T. E. 
(2016) 
CAM + 
DSM-IV 
Elective knee arthroplasty 
22 
76 
73.4±5.1 52.0 serum 
57.0±18.6 
68.4±31.6 
USA 
Shen, H. 
(2016) 
CAM + 
DSM-IV 
Open abdominal surgery 
36 
104 
70.1±6.4 57.2 serum 
50.4±16.2 
67.0±24.1 
China 
Chu, C. S. 
(2016) 
CAM + 
DSM-IV 
Orthopedic surgery 
23 
80 
81.7±4.0 26.2 serum 
97.1±47.4 
96.1±47.6 
Taiwan 
Egberts, A. DOSS + Internal and geriatric ward 23 82.6 53.5 serum *48.1±32.1 Netherland 
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(2015) DSM-IV 63 71.0±43.5 
Cinar, M. A. 
(2014) 
DSM-IV Cardiovascular surgery 
15 
20 
64.2±10.
3 
25.7 serum 
1.44±1.76 
1.03±1.18 
Turkey 
Cerejeira, J. 
(2013) 
CAM + 
DSM-IV 
Elective hip arthroplasty 
37 
64 
73.0±6.3                            50.5 plasma 
*138.3±57.8 
128.2±59.6 
Portugal 
Morandi, A. 
(2011) 
CAM + 
CAM-ICU 
Critically ill mechanically ventilated 
patients 
86 
24 
65 48.2 serum #n/a USA 
Lemstra, A. 
W. 
(2008) 
CAM + 
DSM-IV 
Acute or elective hip surgery 
18 
50 
78.9 69.1 blood 
*109.9 
98.4 
Netherland 
Adamis, D. CAM Elderly medical unit 22 84.6±6.6 67.1 serum 55.8±33.7 UK 
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(2007) 35 75.2±33.7 
Wilson, K. 
(2005) 
CAM + 
DSM-III 
Acute medical ward 
12 
88 
84.5±4.2 69.0 plasma #n/a UK 
 
*: nmol/L convert to ng/ml x 7.63 
#: derived effect sizes from other statistical parameters 
 
Abbreviation: CAM: confusion assessment method; DOSS: Delirium observation screening scale; ELISA: enzyme-linked immunosorbent assay; 
IGF: insulin-like growth factor; n/a: not available; RASS: Richmond agitation-sedation scale; RIA: radioimmunoassay; UK: United Kingdom; 
USA: United States of America. 
Records identified (n=903) 
Duplicated records excluded (n=376) 
Records after duplicates 
removed (n=527) 
Excluded by title and abstract (n=445) 
Full-text articles assessed 
for eligibility (n=82) 
Articles excluded (n=72) 
(1) Meta-analysis 
(2) Commentary 
(3) Review 
(4) The same sample sources 
(5) Data from CSF 
(6) Not about delirium 
(7) Not about IGF-1 
Studies included in 
qualitative synthesis (n=10) 
Ten studies included 
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Additional records identified 
through other sources 
(n=4) 
Records identified through 
database searching 
(n=899) 
Figure
Figure 2 Forest plot of results of pooled  effect sizes of recruited studies 
Hedges' g and 95% CI Study name Statistics for each study 
Hedges' Lower  Upper  
g limit limit p-Value 
-2.00 -1.00 0.00 1.00 2.00 
Lower IGF-1 in delirium Higher IGF-1 in delirium 
Adamis, D. (2007) -0.512 -1.046 0.023 0.061 
Cerejeira, J. (2013) 0.169 -0.234 0.571 0.411 
Chu, C.S. (2016) 0.019 -0.441 0.479 0.936 
Cinar, M.A. (2014) -0.260 -0.917 0.397 0.437 
Egberts, A. (2015) -0.556 -1.036 -0.075 0.023 
Lemstra, A.W. (2008) 0.114 -0.418 0.647 0.674 
Morandi, A. (2011) 0.009 -0.441 0.458 0.970 
Shen, H. (2016) -0.738 -1.125 -0.352 0.000 
Wilson, K. (2005) -0.095 -0.172 -0.018 0.016 
Yen, T.E. (2016) -0.387 -0.861 0.087 0.110 
Overall -0.393 -0.026 -0.209 0.025 
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Supplemental table S1: MOOSE Checklist for Meta-analyses of Observational Studies 
Item No Recommendation Reported on Page No 
Reporting of background should include 
1 Problem definition 6-7 
2 Hypothesis statement 6-7 
3 Description of study outcome(s) 6-7 
4 Type of exposure or intervention used N/A 
5 Type of study designs used 6-7 
6 Study population 6-7 
Reporting of search strategy should include 
7 Qualifications of searchers (eg, librarians and investigators) 8-9 
8 Search strategy, including time period included in the synthesis and key words 8-9 
9 Effort to include all available studies, including contact with authors 8-9 
10 Databases and registries searched 8-10 
11 Search software used, name and version, including special features used (eg, explosion) N/A 
12 Use of hand searching (eg, reference lists of obtained articles) 8-10 
13 List of citations located and those excluded, including justification 
Table 1, 
supplemental 
table S2 
14 Method of addressing articles published in languages other than English 8-10 
15 Method of handling abstracts and unpublished studies 8-10 
16 Description of any contact with authors 8-10, acknowledgement 
Reporting of methods should include 
17 Description of relevance or appropriateness of studies assembled for assessing the hypothesis to be tested 9-11 
18 Rationale for the selection and coding of data (eg, sound clinical principles or convenience) 9-11 
19 Documentation of how data were classified and coded (eg, multiple raters, blinding and interrater reliability) 9-11 
20 Assessment of confounding (eg, comparability of cases and controls in studies where appropriate) 9-11 
21 Assessment of study quality, including blinding of quality assessors, stratification or regression on possible predictors of study results 9-11 
22 Assessment of heterogeneity 9-11 
23 
Description of statistical methods (eg, complete description of fixed or 
random effects models, justification of whether the chosen models account 
for predictors of study results, dose-response models, or cumulative meta-
analysis) in sufficient detail to be replicated 
9-11 
24 Provision of appropriate tables and graphics Table 1, Figure 2 
Reporting of results should include 
25 Graphic summarizing individual study estimates and overall estimate Figure 2 
26 Table giving descriptive information for each study included Table 1, table 2 
27 Results of sensitivity testing (eg, subgroup analysis) 12-15 
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28 Indication of statistical uncertainty of findings 12-15 
Reporting of discussion should include 
29 Quantitative assessment of bias (eg, publication bias) 16-17 
30 Justification for exclusion (eg, exclusion of non-English language citations) 
16-17 
supplementary 
table S2 
31 Assessment of quality of included studies 
16-17, 
supplementary 
table S3 
Reporting of conclusions should include 
32 Consideration of alternative explanations for observed results 21 
33 Generalization of the conclusions (ie, appropriate for the data presented and within the domain of the literature review) 21 
34 Guidelines for future research 21 
35 Disclosure of funding source 22 
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Meta-analysis (n=1) 
Shi, C., Yang, C., Gao, R. and Yuan, W. (2015). Risk Factors for Delirium After Spinal Surgery: A 
Meta-Analysis. World Neurosurgery, 84, 1466-1472. 
 
Commentary (n=1) 
Motosko, C., Brown, K. and Kwatra, M. (2012). Insulin-like growth factor 1 and delirium. Int 
Psychogeriatr, 24, 1872; author reply 1872-1873. 
 
Review (n=18) 
Adamis, D. and Meagher, D. (2011). Insulin-like growth factor I and the pathogenesis of delirium: a 
review of current evidence. J Aging Res, 2011, 951403. 
Benhamou, D. and Brouquet, A. (2016). Postoperative cerebral dysfunction in the elderly: Diagnosis 
and prophylaxis. Journal of Visceral Surgery, 153, S27-S32. 
Cerejeira, J., Firmino, H., Vaz-Serra, A. and Mukaetova-Ladinska, E. B. (2010). The neuroinflammatory 
hypothesis of delirium. Acta Neuropathol, 119, 737-754. 
Cerejeira, J., Lagarto, L. and Mukaetova-Ladinska, E. B. (2014). The immunology of delirium. 
Neuroimmunomodulation, 21, 72-78. 
Cunningham, C. and MacLullich, A. M. J. (2013). At the extreme end of the psychoneuroimmunological 
spectrum: Delirium as a maladaptive sickness behaviour response. Brain, Behavior, and Immunity, 
28, 1-13. 
de Rooij, S. E., van Munster, B. C., Korevaar, J. C. and Levi, M. (2007). Cytokines and acute phase 
response in delirium. Journal of Psychosomatic Research, 62, 521-525. 
Fong, T. G., Davis, D., Growdon, M. E., Albuquerque, A. and Inouye, S. K. (2015). The interface 
between delirium and dementia in elderly adults. The Lancet Neurology, 14, 823-832. 
Gaudreau, J.-D., Gagnon, P., Roy, M.-A., Harel, F. and Tremblay, A. (2005). Association Between 
Psychoactive Medications and Delirium in Hospitalized Patients: A Critical Review. 
Psychosomatics, 46, 302-316. 
Gunther, M. L., Morandi, A. and Ely, E. W. (2008). Pathophysiology of Delirium in the Intensive Care 
Unit. Critical Care Clinics, 24, 45-65. 
Khan, B. A., Zawahiri, M., Campbell, N. L. and Boustani, M. A. (2011). Biomarkers for delirium--a 
review. J Am Geriatr Soc, 59 Suppl 2, S256-261. 
LeGrand, S. B. (2012). Delirium in Palliative Medicine: A Review. Journal of Pain and Symptom 
Management, 44, 583-594. 
  
Maldonado, J. R. (2008). Pathoetiological Model of Delirium: a Comprehensive Understanding of the 
Neurobiology of Delirium and an Evidence-Based Approach to Prevention and Treatment. Critical 
Care Clinics, 24, 789-856. 
Maldonado, J. R. (2017). Acute Brain Failure: Pathophysiology, Diagnosis, Management, and Sequelae 
of Delirium. Critical Care Clinics, 33, 461-519. 
Marcantonio, E. R., Rudolph, J. L., Culley, D., Crosby, G., Alsop, D. and Inouye, S. K. (2006). Serum 
biomarkers for delirium. J Gerontol A Biol Sci Med Sci, 61, 1281-1286. 
Hall, R. J., Shenkin, S. D. and Maclullich, A. M. (2011). A systematic literature review of cerebrospinal 
fluid biomarkers in delirium. Dement Geriatr Cogn Disord, 32, 79-93. 
Haymore, J. B. and Patel, N. (2016). Delirium in the Neuro Intensive Care Unit. Critical Care Nursing 
Clinics of North America, 28, 21-35. 
Rizk, P., Morris, W., Oladeji, P. and Huo, M. (2016). Review of Postoperative Delirium in Geriatric 
Patients Undergoing Hip Surgery. Geriatr Orthop Surg Rehabil, 7, 100-105. 
Simone, M. J. and Tan, Z. S. (2011). The role of inflammation in the pathogenesis of delirium and 
dementia in older adults: a review. CNS Neurosci Ther, 17, 506-513. 
 
The same sample sources (n=4) 
Adamis, D., et al. (2009). Cytokines and IGF-I in delirious and non-delirious acutely ill older medical 
inpatients. Age Ageing, 38, 326-332; discussion 251.--> Same population from Adamis, D., Treloar, 
A., Martin, F. C., Gregson, N., Hamilton, G. and Macdonald, A. J. (2007). APOE and cytokines as 
biological markers for recovery of prevalent delirium in elderly medical inpatients. Int J Geriatr 
Psychiatry, 22, 688-694. 
Adamis, D., Treloar, A., Gregson, N., Macdonald, A. J. and Martin, F. C. (2011). Delirium and the 
functional recovery of older medical inpatients after acute illness: the significance of biological 
factors. Arch Gerontol Geriatr, 52, 276-280. --> Same population from Adamis, D., Treloar, A., 
Martin, F. C., Gregson, N., Hamilton, G. and Macdonald, A. J. (2007). APOE and cytokines as 
biological markers for recovery of prevalent delirium in elderly medical inpatients. Int J Geriatr 
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Adamis, D., et al. (2014). Phenomenological and biological correlates of improved cognitive function in 
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from Adamis, D., Treloar, A., Martin, F. C., Gregson, N., Hamilton, G. and Macdonald, A. J. 
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Supplemental Table S3: Newcastle-Ottawa Quality Assessment Scale (NOS) scores of included studies 
Author (year) Selection Comparability Outcome Total scores 
Yen, T. E. (2016) 4 2 2 8 
Shen, H. (2016) 4 2 1 7 
Chu, C. S. (2016) 4 1 2 7 
Egberts, A. (2015) 4 2 2 8 
Cinar, M. A. (2014) 4 1 2 7 
Cerejeira, J. (2013) 4 1 2 7 
Morandi, A. (2011) 4 2 2 8 
Lemstra, A. W. (2008) 4 1 2 7 
Adamis, D. (2007) 4 2 2 8 
Wilson, K. (2005) 4 2 1 7 
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